• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YBX1的过表达通过GSK3B/细胞周期蛋白D1/细胞周期蛋白E1途径促进胰腺导管腺癌生长。

Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway.

作者信息

Liu Zhiqiang, Li Yongfeng, Li Xiaogang, Zhao Jingyuan, Wu Shihong, Wu Heshui, Gou Shanmiao

机构信息

Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

Mol Ther Oncolytics. 2020 Mar 29;17:21-30. doi: 10.1016/j.omto.2020.03.006. eCollection 2020 Jun 26.

DOI:10.1016/j.omto.2020.03.006
PMID:32300640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7150436/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers due to frequently late diagnosis and futile treatment. It is a crucial necessity to determine the mechanisms of PDAC. Y-box Binding Protein 1 (YBX1), a highly conserved transcription factor, has been previously reported to play a role in various hallmarks of cancer. We show here that YBX1 is significantly overexpressed in PDAC and correlates with poor prognosis and reduced survival. In PDAC cell lines, YBX1 regulated cell-cycle progression, proliferation, and the expression of glycogen synthase kinase 3 beta (GSK3B) and cell-cycle-related proteins cyclin D1 and E1. Dual-luciferase reporter and chromatin immunoprecipitation (ChIP) assays established that YBX1 binds to the promoter of , suggesting that YBX1 promotes pancreatic cancer cell growth through induction of GSK3B expression. These findings offer important insights into the mechanisms underlying pathologic proliferation in PDAC.

摘要

胰腺导管腺癌(PDAC)是最致命的癌症之一,原因是其诊断常常较晚且治疗效果不佳。确定PDAC的发病机制至关重要。Y盒结合蛋白1(YBX1)是一种高度保守的转录因子,此前已有报道称其在癌症的各种特征中发挥作用。我们在此表明,YBX1在PDAC中显著过表达,且与预后不良和生存率降低相关。在PDAC细胞系中,YBX1调节细胞周期进程、增殖以及糖原合酶激酶3β(GSK3B)和细胞周期相关蛋白细胞周期蛋白D1和E1的表达。双荧光素酶报告基因和染色质免疫沉淀(ChIP)分析表明,YBX1与 的启动子结合,提示YBX1通过诱导GSK3B表达促进胰腺癌细胞生长。这些发现为PDAC病理性增殖的潜在机制提供了重要见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/002bc3e28b22/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/111b7ef19700/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/d268549c9122/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/c07f1ae94fac/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/ed7720382cc1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/4c0fefaf0434/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/9bae54c1c4f8/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/002bc3e28b22/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/111b7ef19700/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/d268549c9122/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/c07f1ae94fac/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/ed7720382cc1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/4c0fefaf0434/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/9bae54c1c4f8/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ecf/7150436/002bc3e28b22/gr7.jpg

相似文献

1
Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway.YBX1的过表达通过GSK3B/细胞周期蛋白D1/细胞周期蛋白E1途径促进胰腺导管腺癌生长。
Mol Ther Oncolytics. 2020 Mar 29;17:21-30. doi: 10.1016/j.omto.2020.03.006. eCollection 2020 Jun 26.
2
Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G/M phase in ovarian cancer.Y 盒结合蛋白 1/细胞周期蛋白 A1 轴特异性促进卵巢癌细胞在 G/M 期的细胞周期进程。
Sci Rep. 2024 Sep 17;14(1):21701. doi: 10.1038/s41598-024-72174-9.
3
YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.YBX1通过细胞周期蛋白依赖性激酶25A(CDC25a)途径调控人肺腺癌中的肿瘤生长。
Oncotarget. 2016 Dec 13;7(50):82139-82157. doi: 10.18632/oncotarget.10080.
4
YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma.YBX1通过转录调控肺腺癌中的MUC1增强转移和干性。
Front Oncol. 2021 Dec 15;11:702491. doi: 10.3389/fonc.2021.702491. eCollection 2021.
5
Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.DIXDC1的过表达与人类胰腺导管腺癌中增强的细胞生长及不良预后相关。
Hum Pathol. 2016 Nov;57:182-192. doi: 10.1016/j.humpath.2016.07.015. Epub 2016 Aug 3.
6
RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.RACK1过表达与胰腺导管腺癌的生长及不良预后相关。
Exp Mol Pathol. 2016 Oct;101(2):176-186. doi: 10.1016/j.yexmp.2016.08.001. Epub 2016 Aug 3.
7
RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells binding to AURKA mRNA.RNA 结合蛋白 YBX1 通过与 AURKA mRNA 结合促进鼻咽癌细胞的增殖和侵袭。
J Cancer. 2021 Apr 7;12(11):3315-3324. doi: 10.7150/jca.56262. eCollection 2021.
8
Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells.染色体盒同源物8(CBX8)与Y盒结合蛋白1(YBX1)相互作用,以促进肝癌细胞的细胞增殖。
Aging (Albany NY). 2019 Sep 8;11(17):7123-7149. doi: 10.18632/aging.102241.
9
Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway.Gasdermin E 通过 YBX1-黏蛋白途径介导胰腺导管腺癌对酶消化的抵抗。
Nat Cell Biol. 2022 Mar;24(3):364-372. doi: 10.1038/s41556-022-00857-4. Epub 2022 Mar 15.
10
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.自分泌介导的STAT3的ErbB-2激酶激活是胰腺癌细胞系生长因子非依赖性所必需的。
Oncogene. 2003 Oct 30;22(49):7781-95. doi: 10.1038/sj.onc.1206966.

引用本文的文献

1
YBX1: an RNA/DNA-binding protein that affects disease progression.YBX1:一种影响疾病进展的RNA/DNA结合蛋白。
Front Oncol. 2025 Jul 29;15:1635209. doi: 10.3389/fonc.2025.1635209. eCollection 2025.
2
Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers.5-甲基胞嘧啶RNA结合蛋白的生物学功能及其在人类癌症中的潜在机制
Front Oncol. 2025 Feb 7;15:1534948. doi: 10.3389/fonc.2025.1534948. eCollection 2025.
3
TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway.

本文引用的文献

1
YB-1 expression promotes pancreatic cancer metastasis that is inhibited by microRNA-216a.YB-1的表达促进胰腺癌转移,而这一过程受到微小RNA-216a的抑制。
Exp Cell Res. 2017 Oct 15;359(2):319-326. doi: 10.1016/j.yexcr.2017.07.039. Epub 2017 Aug 3.
2
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.GEPIA:一个用于癌症和正常基因表达谱分析及交互式分析的网络服务器。
Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102. doi: 10.1093/nar/gkx247.
3
Cancer Statistics, 2017.《2017 年癌症统计》
TRIM29通过泛素化和降解YBX1以抑制PI3K/AKT通路,从而逆转肝癌细胞对乐伐替尼的耐药性。
Transl Oncol. 2025 Mar;53:102294. doi: 10.1016/j.tranon.2025.102294. Epub 2025 Jan 28.
4
YBX1: A Multifunctional Protein in Senescence and Immune Regulation.YBX1:衰老与免疫调节中的一种多功能蛋白
Curr Issues Mol Biol. 2024 Dec 13;46(12):14058-14079. doi: 10.3390/cimb46120841.
5
induces autophagic and apoptotic cell death in pancreatic cancer cells.诱导胰腺癌细胞发生自噬性和凋亡性细胞死亡。
Front Pharmacol. 2024 Jul 30;15:1412565. doi: 10.3389/fphar.2024.1412565. eCollection 2024.
6
Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential.Y 盒结合蛋白 1:揭开其在癌症发展中的多方面作用及其治疗潜力。
Int J Mol Sci. 2024 Jan 5;25(2):717. doi: 10.3390/ijms25020717.
7
Beraprost sodium attenuates the development of myocardial fibrosis after myocardial infarction by regulating GSK-3β expression in rats.贝前列素钠通过调节大鼠 GSK-3β表达减轻心肌梗死后心肌纤维化的发展。
Immun Inflamm Dis. 2023 Nov;11(11):e1050. doi: 10.1002/iid3.1050.
8
NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer.NSUN2通过增强胰腺癌中TIAM2 mRNA的稳定性来促进肿瘤进展。
Cell Death Discov. 2023 Jul 1;9(1):219. doi: 10.1038/s41420-023-01521-y.
9
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.一种与m5C甲基化调节因子相关的特征可预测胰腺癌的预后和治疗反应。
Front Cell Dev Biol. 2022 Aug 19;10:975684. doi: 10.3389/fcell.2022.975684. eCollection 2022.
10
Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.老狗学新招:重新激活的发育信号通路调控癌症中的ABCB1及化疗耐药性
Cancer Drug Resist. 2021 Jun 19;4(2):424-452. doi: 10.20517/cdr.2020.114. eCollection 2021.
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
4
Therapeutic Advances in Localized Pancreatic Cancer.局部胰腺癌治疗进展。
JAMA Surg. 2016 Sep 1;151(9):862-8. doi: 10.1001/jamasurg.2016.1113.
5
Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.可溶性B7-H3通过TLR4/NF-κB通路促进胰腺癌细胞的侵袭和转移。
Sci Rep. 2016 Jun 8;6:27528. doi: 10.1038/srep27528.
6
Pancreatic cancer.胰腺癌。
Lancet. 2016 Jul 2;388(10039):73-85. doi: 10.1016/S0140-6736(16)00141-0. Epub 2016 Jan 30.
7
Pancreatic adenocarcinoma.胰腺腺癌
N Engl J Med. 2014 Nov 27;371(22):2140-1. doi: 10.1056/NEJMc1412266.
8
Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.慢性胰腺炎和胰腺癌表现出活跃的上皮间质转化特征,受 miR-217-SIRT1 通路调控。
Cancer Lett. 2014 Dec 28;355(2):184-91. doi: 10.1016/j.canlet.2014.08.007. Epub 2014 Aug 27.
9
Y-box binding protein 1--a prognostic marker and target in tumour therapy.Y 盒结合蛋白 1——一种肿瘤治疗的预后标志物和靶点。
Eur J Cell Biol. 2014 Jan-Feb;93(1-2):61-70. doi: 10.1016/j.ejcb.2013.11.007. Epub 2013 Dec 27.
10
Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action.低浓度二甲双胍选择性抑制胰腺癌中 CD133 ⁺ 细胞的增殖并发挥抗癌作用。
PLoS One. 2013 May 8;8(5):e63969. doi: 10.1371/journal.pone.0063969. Print 2013.